Compound Profile: Trazonil
Trazonil 50 mg is a research-grade preparation containing trazodone hydrochloride, a triazolopyridine derivative antidepressant compound manufactured by Intas Pharmaceuticals. This pharmaceutical-grade research material enables laboratory investigation into serotonin receptor modulation mechanisms and neuropharmacological pathways. Research scientists studying neurochemistry and psychopharmacology utilize this compound to examine its complex receptor interactions and metabolic profiles in controlled laboratory environments.
Laboratory Applications
Researchers investigate trazodone’s multifaceted pharmacology, including its primary mechanism as a serotonin reuptake inhibitor combined with 5-HT2A receptor antagonism. Laboratory studies examine its unique receptor binding profile, which distinguishes it from other antidepressant classes available through Stroid UK Shop. Scientists analyse its metabolic pathways, including the formation of active metabolite m-chlorophenylpiperazine (mCPP), and evaluate its interactions with various neurotransmitter systems. Research applications extend to studying its effects on sleep architecture and circadian rhythm modulation in experimental models. Comparative studies with SARMs research compounds and peptide modulators provide insights into different therapeutic mechanisms. Investigators examine its dose-response relationships and pharmacokinetic properties across various research protocols. Studies focus on its sedative properties through histamine H1 receptor antagonism and alpha-1 adrenergic blockade. Research teams evaluate its potential interactions with other compounds in the trazodone research category to understand synergistic effects and metabolic interference patterns.
Product Specifications
| Active Compound | Trazodone hydrochloride |
|---|---|
| Strength | 50 mg per tablet |
| Manufacturer | Intas Pharmaceuticals |
| Molecular Formula | C₁₉H₂₂ClN₅O (verify with supplier) |
| CAS Number | Verify with supplier |
| Storage | Room temperature, dry conditions |
Research Compliance
This trazodone hydrochloride research material is intended exclusively for in-vitro laboratory research and analytical testing purposes. Not approved for human consumption, therapeutic use, or any clinical application. Researchers must maintain appropriate laboratory safety protocols and disposal procedures when handling this pharmaceutical research compound.
